Merial, a major player in the animal health sector, has gained full-licensure from the U.S. Department of Agriculture for ONCEPT(TM) Canine Melanoma Vaccine, DNA. ONCEPT is a breakthrough vaccine indicated for aiding in extending survival of dogs with stage II or stage III oral canine melanoma, a common yet deadly form of cancer in dogs.
ONCEPT is the first and only USDA-approved, therapeutic vaccine for the treatment of cancer – in either animals or humans.
Source: DogMagazine.net – the K9 Magazine blog
Canine Cancer Breakthrough: Could This Be First Effective Cancer Vaccination?
Related content: